Results 191 to 200 of about 4,295 (215)

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

Annals of Oncology, 2003
exaly  

Efficacy of palonosetron in postoperative nausea and vomiting (PONV)—a meta-analysis

Journal of Clinical Anesthesia, 2016
Preet Mohinder Singh, Basavana Goudra, jeetinder Kaur makkar   +2 more
exaly  

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Annals of Oncology, 2006
exaly  

Palonosetron/sevoflurane

Reactions Weekly, 2015
openaire   +1 more source

Dexamethasone/palonosetron

Reactions Weekly, 2015
openaire   +1 more source

Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting

Drugs, 2015
exaly  

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study

Annals of Oncology, 2014
exaly  

Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study

Lancet Oncology, The, 2016
exaly  

Palonosetron: profile report

Drugs & Therapy Perspectives, 2004
openaire   +1 more source

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Annals of Oncology, 2014
exaly